18 October 2017
An agreement on cooperation between the Association of Kaluga Pharmaceutical Cluster and Steinbeis Global Institute Tübingen at the Steinbeis University Berlin was signed on October 16 by Irina Novikova, the Executive Director of the Association, and Prof. Dr. Bertram Lohmüller, Director of the Institute.
The agreement provides for the implementation of a number of joint training and professional development programs for participants of Kaluga Pharmaceutical Cluster, including such programs as Global Technology Management (Master’s program), Manufacturing and Entry into Global Markets (MBA), Technology Transfer and Business Development MBA), and a number of programs in the area of health care and pharmaceutical manufacturing. According to the mutual arrangement, Steinbeis Global Institute will provide consulting and organizational support to small and medium-sized companies participating in the cluster in their search for partners in Germany and in bringing their products to the European market. For its part, Kaluga Pharmaceutical Cluster will become a “point of entry” to the Russian market for German companies in the area of pharmaceuticals. The agreement also provides for sharing the results of research conducted by the parties, scientific and methodological materials and educational programs.
This agreement was signed during the practical training program for executives from the companies participating in Kaluga Pharmaceutical Cluster in Baden-Württemberg with the active support of the Baden-Württemberg Export Academy.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024